BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42 | -99.9% | 1,100 | 0.0% | 0.02% | -12.5% |
| Q2 2023 | $50,116 | -42.1% | 1,100 | -48.5% | 0.02% | -45.5% |
| Q1 2023 | $86,555 | +79308.3% | 2,134 | 0.0% | 0.04% | -22.8% |
| Q4 2022 | $109 | -99.9% | 2,134 | -31.9% | 0.06% | -38.0% |
| Q3 2022 | $169,000 | -31.3% | 3,133 | -18.3% | 0.09% | -28.7% |
| Q2 2022 | $246,000 | -17.2% | 3,834 | 0.0% | 0.13% | -3.7% |
| Q1 2022 | $297,000 | -9.7% | 3,834 | 0.0% | 0.13% | +10.7% |
| Q4 2021 | $329,000 | -28.0% | 3,834 | -32.5% | 0.12% | -31.6% |
| Q3 2021 | $457,000 | -0.2% | 5,684 | 0.0% | 0.18% | -1.7% |
| Q2 2021 | $458,000 | -4.4% | 5,684 | 0.0% | 0.18% | -12.2% |
| Q1 2021 | $479,000 | +5.0% | 5,684 | 0.0% | 0.20% | -3.3% |
| Q4 2020 | $456,000 | -0.2% | 5,684 | 0.0% | 0.21% | -15.5% |
| Q3 2020 | $457,000 | -9.9% | 5,684 | -3.4% | 0.25% | -13.1% |
| Q2 2020 | $507,000 | +6.1% | 5,884 | 0.0% | 0.29% | -11.6% |
| Q1 2020 | $478,000 | -2.8% | 5,884 | 0.0% | 0.33% | +18.1% |
| Q4 2019 | $492,000 | -4.5% | 5,884 | 0.0% | 0.28% | -8.6% |
| Q3 2019 | $515,000 | +6.8% | 5,884 | 0.0% | 0.30% | +5.2% |
| Q2 2019 | $482,000 | -2.6% | 5,884 | -3.3% | 0.29% | -7.1% |
| Q1 2019 | $495,000 | -99.9% | 6,084 | 0.0% | 0.31% | +9.2% |
| Q4 2018 | $400,449,000 | -18.0% | 6,084 | -3.9% | 0.28% | +0.7% |
| Q3 2018 | $488,288,000 | +4.4% | 6,334 | 0.0% | 0.28% | -1.1% |
| Q2 2018 | $467,703,000 | +13.5% | 6,334 | 0.0% | 0.28% | +16.8% |
| Q1 2018 | $411,963,000 | -8.3% | 6,334 | -8.9% | 0.24% | -11.6% |
| Q4 2017 | $449,183,000 | +2.4% | 6,949 | -0.6% | 0.28% | +6.2% |
| Q3 2017 | $438,560,000 | +3.7% | 6,989 | 0.0% | 0.26% | +1.2% |
| Q2 2017 | $423,114,000 | +41.3% | 6,989 | +21.0% | 0.26% | +39.7% |
| Q1 2017 | $299,440,000 | +17.0% | 5,774 | 0.0% | 0.18% | +7.0% |
| Q4 2016 | $256,019,000 | -11.1% | 5,774 | -4.5% | 0.17% | -13.1% |
| Q3 2016 | $287,932,000 | +37.0% | 6,049 | +30.1% | 0.20% | +30.3% |
| Q2 2016 | $210,228,000 | +5.5% | 4,649 | -4.1% | 0.15% | -0.7% |
| Q1 2016 | $199,197,000 | +7.7% | 4,849 | 0.0% | 0.15% | +6.2% |
| Q4 2015 | $184,989,000 | +16.1% | 4,849 | 0.0% | 0.14% | +11.6% |
| Q3 2015 | $159,290,000 | -53.0% | 4,849 | 0.0% | 0.13% | -48.8% |
| Q2 2015 | $339,091,000 | +1.5% | 4,849 | -0.6% | 0.25% | +2.9% |
| Q1 2015 | $334,212,000 | -6.5% | 4,879 | 0.0% | 0.24% | -5.8% |
| Q4 2014 | $357,582,000 | +2.1% | 4,879 | 0.0% | 0.26% | -0.8% |
| Q3 2014 | $350,166,000 | -0.7% | 4,879 | 0.0% | 0.26% | +2.3% |
| Q2 2014 | $352,752,000 | -1.7% | 4,879 | 0.0% | 0.26% | -2.7% |
| Q1 2014 | $358,997,000 | +5.8% | 4,879 | 0.0% | 0.26% | +5.2% |
| Q4 2013 | $339,334,000 | +5.9% | 4,879 | 0.0% | 0.25% | -0.4% |
| Q3 2013 | $320,502,000 | -5.7% | 4,879 | -0.5% | 0.25% | -11.3% |
| Q2 2013 | $339,700,000 | – | 4,904 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |